Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

A Phase 1/2, First-in-Human, Open-Label, Dose-Escalation Study of TAK-280 in Patients with Unresectable Locally Advanced or Metastatic Cancer


Collapse Overview 
Collapse sponsor award id
TAK-280-1501


Collapse Biography 

Collapse Time 
Collapse start date
2024-04-16

Collapse end date
2034-04-15